Viking Therapeutics: Canaccord Genuity cuts target price to $106 from $114
VKTX•Canaccord Genuity cut its target price for Viking Therapeutics to $106 from $114.
Related News
Brent hits five-month high as attacks on ships, Saudi sites fuel supply worries
USO•
Gold eases as elevated oil prices keep inflation risks in focus
GLD•
Nasdaq trade halt continues, reason not available at 03:58 am
PC•
Victoria's Secret & Co.: Barclays raises target price to $112 from $106
VSCO•
Nasdaq trade halt continues; reason not available at 03:58 a.m.
OST•